Mismatch Repair Proficient Colorectal Cancer
3 clinical trials · Condition
◉ Watch Mismatch Repair Proficient Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors (NCT03851614) | University Health Network, Toronto | 2019-04-08 |
| Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC) (NCT02437136) | Syndax Pharmaceuticals | 2015-08-26 |
| A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread (NCT02060188) | Bristol-Myers Squibb | 2014-03-12 |
Track Mismatch Repair Proficient Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.